Stocks
Themes
Market Cap Ranking
Trading Strategies
SEC Filings TLDR
Analysis Reports
Sign in
Loading stock data...
Loading updates and signals...
Back
KMDA
$6.92
-0.43%
Analyze
1M
+3.7%
3M
-10.4%
1Y
+31.1%
Market Cap:
$397.93M
Kamada
Healthcare |
Drug Manufacturers - Specialty & Generic
Kamada Ltd. develops, produces and markets plasma-derived protein therapies for orphan indications. The company is headquartered in Rehovot, Israel.
Click "Analyze" to generate stock analysis
KMDA Price Trend and Signals
KMDA Option Volumes & Open Interests (aggregated)
KMDA Put Call Ratios and IV (aggregated)
KMDA Financials
Signals
News
SEC Filings
Holders
Research Reports
AI Analysis
2025-10-20
Somewhat Bullish
price_signal
Monthly high detected.
2025-10-15
Neutral
volume_signal
Abnormal volume detected compared to 3 mon moving average.
2025-10-15
Somewhat Bearish
price_signal
Quarterly low detected.